Religare Enterprises Limited has issued a clarification to rectify a clerical and typographical error in its earlier announcement dated November 12, 2026. The company has corrected the number of Employee Stock Options (ESOPs) granted. The previously stated figure of 25,998 options has been revised to 5,80,998 options. This correction pertains to the total grant size and does not alter other information previously released regarding the ESOP scheme.
Religare Enterprises Clarifies ESOP Grant Details
Religare Enterprises Limited has submitted a clarification to the National Stock Exchange of India Ltd. and BSE Limited concerning its prior announcement dated November 12, 2026, which detailed the grant of Employee Stock Options (ESOPs). The company has identified and corrected a significant typographical error in the number of options granted.
Correction of Granted Options
The initial announcement mistakenly stated that 25,998 (Twenty Five Thousand Nine Hundred Ninety Eight) stock options were granted. Religare Enterprises has now rectified this to the correct figure of 5,80,998 (Five Lakh Eighty Thousand Nine Hundred and Ninety Eight) stock options. This revised number reflects the actual quantum of ESOPs granted to eligible employees under the company’s scheme.
Revised Disclosure
The company has provided a revised enclosure, marked as Annexure-A, which supersedes the previously submitted information. Religare Enterprises has emphasized that, apart from the corrected number of options, all other details pertaining to the grant and the ESOP scheme remain unchanged from the letter dated November 12, 2026. The meeting duration for this internal communication was from 01:09 P.M. to 02:25 P.M.
ESOP Scheme Overview
The ESOP scheme, approved by the Board of Directors and Shareholders, is in conformity with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. A total of 5,80,998 Equity Shares are covered by these options, with each stock option convertible into one equity share of face value Rs. 10/-. The exercise price for these options is set at Rs. 230.78/- per equity share. The vesting schedule involves 5 equal annual installments of 20% each, commencing one year from the grant date. Options must be exercised no later than 8 years from the date of vesting.
Source: BSE
